Scienion, Maine Manufacturing Reach Distribution Deal for FAST Array Products

Sep 10, 2012

|

NEW YORK (GenomeWeb News) – Scienion and Maine Manufacturing today announced a non-exclusive distribution deal for Maine's FAST protein array products.

The deal includes worldwide marketing of the complete FAST Slide product line, which is built around the nitrocellulose coated FAST Slide. The product line includes the FAST Quant micro ELISA arrays with specific cytokine antibody panels, the Serum Biomarker Chip family of immunoassays for measuring cellular growth proteins, and accessories and consumables.

Financial and other terms of the deal were not announced.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Commission's First Meeting

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

More Scrutiny

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Web of Neutrophil DNA

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

Science Explores Method to Infer Genotype-by-Environment Interactions

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.

Featured White Papers

Automated Library Preparation for the MCI Advantage Cancer Panel Utilizing the Beckman Coulter Biomek i5 Span-8 NGS Workstation

Optimized NGS Library Preparation with Acoustic Liquid Handling

Sep

16

Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu